Chugai Pharmaceutical Co., Ltd.
CHGCF
$47.72
$1.312.82%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 30.90% | -12.52% | |||
| Total Other Revenue | 2.25% | -22.01% | |||
| Total Revenue | 26.97% | -13.95% | |||
| Cost of Revenue | 14.80% | -21.21% | |||
| Gross Profit | 32.38% | -10.28% | |||
| SG&A Expenses | 15.18% | -26.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -410.41% | 101.48% | |||
| Total Operating Expenses | 9.49% | -10.47% | |||
| Operating Income | 50.97% | -18.32% | |||
| Income Before Tax | 51.40% | -19.04% | |||
| Income Tax Expenses | 75.39% | -19.50% | |||
| Earnings from Continuing Operations | 43.18% | -18.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 43.18% | -18.89% | |||
| EBIT | 50.97% | -18.32% | |||
| EBITDA | 50.75% | -23.01% | |||
| EPS Basic | 43.17% | -18.90% | |||
| Normalized Basic EPS | 51.41% | -19.06% | |||
| EPS Diluted | 43.17% | -18.90% | |||
| Normalized Diluted EPS | 51.37% | -19.06% | |||
| Average Basic Shares Outstanding | 0.01% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.99% | 215.44% | |||